Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Acute Myeloid Leukemia (Secondary AML, sAML)”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Study completedNCT01890746
What this trial is testing

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Who this might be right for
Acute Leukaemia
Novartis Pharmaceuticals 148
Large-scale testing (Phase 3)UnknownNCT00715637
What this trial is testing

Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study

Who this might be right for
Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
Antisoma Research 420
Early research (Phase 1)Study completedNCT00903422
What this trial is testing

Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)

Who this might be right for
Myelodysplastic Syndrome
GlaxoSmithKline 98
Testing effectiveness (Phase 2)Looking for participantsNCT05807932
What this trial is testing

Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

Who this might be right for
Myelodysplastic SyndromesSecondary Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Heinrich-Heine University, Duesseldorf 38
Large-scale testing (Phase 3)Ended earlyNCT01203228
What this trial is testing

Dose-reduced Versus Standard Conditioning in MDS/sAML

Who this might be right for
Myelodysplastic SyndromesSecondary Acute Myeloid Leukemia
European Society for Blood and Marrow Transplantation 129
Testing effectiveness (Phase 2)UnknownNCT05513131
What this trial is testing

Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAML

Who this might be right for
Secondary Acute Myeloid Leukemia
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)Study completedNCT04620681
What this trial is testing

CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML

Who this might be right for
Myelodysplastic SyndromesSecondary Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 19
Testing effectiveness (Phase 2)Looking for participantsNCT05584761
What this trial is testing

Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic Leukemia-2Secondary Acute Myeloid Leukemia
The First Affiliated Hospital with Nanjing Medical University 50
Early research (Phase 1)Looking for participantsNCT07250646
What this trial is testing

Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis

Who this might be right for
Secondary AMLMyelofibrosis
Aspera Biomedicines, Inc. 28
Large-scale testing (Phase 3)UnknownNCT00002926
What this trial is testing

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 80